v3.22.4
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Jan. 31, 2020   212,948        
Beginning balance at Jan. 31, 2020 $ 742,607 $ 106 $ 1,378,479 $ (637,487) $ 1,009 $ 500
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   7,752        
Issuance of common stock upon exercise of options 28,831 $ 6 28,825      
Issuance of common stock under RSU and PSU release (in shares)   1,994        
Issuance of common stock under employee stock purchase plan (in shares)   1,030        
Issuance of common stock under employee stock purchase plan 34,263   34,263      
Vesting of early exercised options 3,318   3,318      
Stock-based compensation expense 149,375   149,375      
Capitalized stock-based compensation 3,686   3,686      
Fair value of replacement equity awards attributable to pre-acquisition service 313   313      
Net income (loss) (92,629)     (92,629)    
Non-controlling interest 800         800
Other comprehensive income (loss) 1,310       1,310  
Ending balance (in shares) at Jan. 31, 2021   223,724        
Ending balance at Jan. 31, 2021 871,874 $ 112 1,598,259 (730,116) 2,319 1,300
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares)   2,598        
Issuance of common stock upon exercise of options 15,899 $ 1 15,898      
Issuance of common stock under RSU and PSU release (in shares)   3,408        
Issuance of common stock under RSU and PSU release 0 $ 2 (2)      
Issuance of common stock under employee stock purchase plan (in shares)   904        
Issuance of common stock under employee stock purchase plan 50,277   50,277      
Issuance of common stock for restricted stock awards   57        
Vesting of early exercised options 3,165   3,165      
Stock-based compensation expense 305,792   305,792      
Capitalized stock-based compensation 10,879   10,879      
Fair value of replacement equity awards attributable to pre-acquisition service 4,011   4,011      
Net income (loss) (232,378)     (234,802)   2,424
Non-controlling interest 8,155         8,155
Other comprehensive income (loss) (3,559)       (3,559)  
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   15        
Issuance of common stock for founders holdbacks related to acquisitions 3,528   3,528      
Ending balance (in shares) at Jan. 31, 2022   230,706        
Ending balance at Jan. 31, 2022 $ 1,037,643 $ 115 1,991,807 (964,918) (1,240) 11,879
Stockholders' Deficit            
Issuance of common stock upon exercise of options (in shares) 1,032 1,032        
Issuance of common stock upon exercise of options $ 8,655 $ 3 8,652      
Issuance of common stock under RSU and PSU release (in shares)   3,444        
Issuance of common stock under employee stock purchase plan (in shares)   517        
Issuance of common stock under employee stock purchase plan 59,419   59,419      
Issuance of common stock for restricted stock awards   6        
Vesting of early exercised options 2,204   2,204      
Stock-based compensation expense 519,735   519,735      
Capitalized stock-based compensation 20,193   20,193      
Fair value of replacement equity awards attributable to pre-acquisition service 50   50      
Net income (loss) (182,285)     (183,245)   960
Non-controlling interest 10,954         10,954
Other comprehensive income (loss) 221       221  
Issuance of common stock for founders holdbacks related to acquisitions (in shares)   72        
Issuance of common stock for founders holdbacks related to acquisitions 10,645   10,645      
Ending balance (in shares) at Jan. 31, 2023   235,777        
Ending balance at Jan. 31, 2023 $ 1,487,434 $ 118 $ 2,612,705 $ (1,148,163) $ (1,019) $ 23,793